HEADER IMMUNE SYSTEM 15-SEP-06 2DYP TITLE CRYSTAL STRUCTURE OF LILRB2(LIR2/ILT4/CD85D) COMPLEXED WITH HLA-G COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHA CHAIN G; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES IN DATA BASE 25-300; COMPND 5 SYNONYM: HLA G ANTIGEN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES IN DATA BASE 24-219; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: 9 MER PEPTIDE FROM HISTONE H2A.X; COMPND 15 CHAIN: C; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 4; COMPND 18 MOLECULE: LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER COMPND 19 2; COMPND 20 CHAIN: D; COMPND 21 SYNONYM: LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR 2, LIR-2, COMPND 22 IMMUNOGLOBULIN- LIKE TRANSCRIPT 4, ILT-4, MONOCYTE/MACROPHAGE COMPND 23 IMMUNOGLOBULIN-LIKE RECEPTOR 10, MIR-10, CD85D ANTIGEN; COMPND 24 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGMT7; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PGMT7; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED; SOURCE 22 MOL_ID: 4; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 28 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PGMT7 KEYWDS IMMUNOGLOBULIN-LIKE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.SHIROISHI,K.KUROKI,L.RASUBALA,D.KOHDA,K.MAENAKA REVDAT 4 25-OCT-23 2DYP 1 REMARK REVDAT 3 10-NOV-21 2DYP 1 SEQADV REVDAT 2 24-FEB-09 2DYP 1 VERSN REVDAT 1 07-NOV-06 2DYP 0 JRNL AUTH M.SHIROISHI,K.KUROKI,L.RASUBALA,K.TSUMOTO,I.KUMAGAI, JRNL AUTH 2 E.KURIMOTO,K.KATO,D.KOHDA,K.MAENAKA JRNL TITL STRUCTURAL BASIS FOR RECOGNITION OF THE NONCLASSICAL MHC JRNL TITL 2 MOLECULE HLA-G BY THE LEUKOCYTE IG-LIKE RECEPTOR B2 JRNL TITL 3 (LILRB2/LIR2/ILT4/CD85D) JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 16412 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 17056715 JRNL DOI 10.1073/PNAS.0605228103 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1719921.490 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 25424 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1825 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3844 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE : 0.3540 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 303 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4610 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.72000 REMARK 3 B22 (A**2) : 7.72000 REMARK 3 B33 (A**2) : -15.44000 REMARK 3 B12 (A**2) : 9.54000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 44.20 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000026007. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25468 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 10.80 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 11.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2D31, 2GW5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH8.0, 45% PEG400, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.24433 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 124.48867 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 124.48867 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 62.24433 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE INTERACTION BETWEEN HLA-G (THE MOLECULE COMPOSED OF REMARK 300 CHAIN A/B/C) AND LILRB2 (CHAIN D) IS A BIOLOGICAL UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 GLY D 1 REMARK 465 THR D 2 REMARK 465 GLY D 136 REMARK 465 GLU D 137 REMARK 465 ASP D 138 REMARK 465 PRO D 148 REMARK 465 HIS D 149 REMARK 465 ALA D 150 REMARK 465 ARG D 151 REMARK 465 GLY D 152 REMARK 465 PRO D 196 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU D 11 CG CD OE1 OE2 REMARK 470 ASN D 166 CG OD1 ND2 REMARK 470 ARG D 167 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO D 52 C - N - CD ANGL. DEV. = -19.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -123.99 63.47 REMARK 500 TYR A 123 -72.64 -118.70 REMARK 500 PHE A 195 -129.79 51.70 REMARK 500 PRO A 210 -176.41 -69.71 REMARK 500 GLU A 222 135.48 172.25 REMARK 500 THR A 225 -25.90 -29.79 REMARK 500 LYS A 243 142.37 -172.12 REMARK 500 GLU A 253 11.04 -148.52 REMARK 500 ILE B 1 123.26 95.82 REMARK 500 TRP B 60 -15.30 75.32 REMARK 500 LYS D 41 -4.79 56.02 REMARK 500 TRP D 46 -158.45 -56.67 REMARK 500 ILE D 47 -36.41 75.73 REMARK 500 PRO D 52 -44.54 -162.05 REMARK 500 HIS D 140 100.29 69.63 REMARK 500 SER D 146 -138.61 -100.99 REMARK 500 ASN D 166 48.38 -84.64 REMARK 500 SER D 180 74.36 -161.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YPD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-G MONOMER REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-G DIMER REMARK 900 RELATED ID: 2GW5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LILRB2 DBREF 2DYP A 1 276 UNP P17693 HLAG_HUMAN 25 300 DBREF 2DYP B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2DYP C 1 9 UNP P16104 H2AX_HUMAN 78 86 DBREF 2DYP D 1 196 UNP Q8N423 LIRB2_HUMAN 24 219 SEQADV 2DYP MET A 0 UNP P17693 INITIATING METHIONINE SEQADV 2DYP SER A 42 UNP P17693 CYS 66 ENGINEERED MUTATION SEQADV 2DYP MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 2DYP ARG D 61 UNP Q8N423 HIS 84 SEE REMARK 999 SEQRES 1 A 277 MET GLY SER HIS SER MET ARG TYR PHE SER ALA ALA VAL SEQRES 2 A 277 SER ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA MET SEQRES 3 A 277 GLY TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER SEQRES 4 A 277 ASP SER ALA SER PRO ARG MET GLU PRO ARG ALA PRO TRP SEQRES 5 A 277 VAL GLU GLN GLU GLY PRO GLU TYR TRP GLU GLU GLU THR SEQRES 6 A 277 ARG ASN THR LYS ALA HIS ALA GLN THR ASP ARG MET ASN SEQRES 7 A 277 LEU GLN THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA SEQRES 8 A 277 SER SER HIS THR LEU GLN TRP MET ILE GLY CYS ASP LEU SEQRES 9 A 277 GLY SER ASP GLY ARG LEU LEU ARG GLY TYR GLU GLN TYR SEQRES 10 A 277 ALA TYR ASP GLY LYS ASP TYR LEU ALA LEU ASN GLU ASP SEQRES 11 A 277 LEU ARG SER TRP THR ALA ALA ASP THR ALA ALA GLN ILE SEQRES 12 A 277 SER LYS ARG LYS CYS GLU ALA ALA ASN VAL ALA GLU GLN SEQRES 13 A 277 ARG ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU SEQRES 14 A 277 HIS ARG TYR LEU GLU ASN GLY LYS GLU MET LEU GLN ARG SEQRES 15 A 277 ALA ASP PRO PRO LYS THR HIS VAL THR HIS HIS PRO VAL SEQRES 16 A 277 PHE ASP TYR GLU ALA THR LEU ARG CYS TRP ALA LEU GLY SEQRES 17 A 277 PHE TYR PRO ALA GLU ILE ILE LEU THR TRP GLN ARG ASP SEQRES 18 A 277 GLY GLU ASP GLN THR GLN ASP VAL GLU LEU VAL GLU THR SEQRES 19 A 277 ARG PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA SEQRES 20 A 277 VAL VAL VAL PRO SER GLY GLU GLU GLN ARG TYR THR CYS SEQRES 21 A 277 HIS VAL GLN HIS GLU GLY LEU PRO GLU PRO LEU MET LEU SEQRES 22 A 277 ARG TRP LYS GLN SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ARG ILE ILE PRO ARG HIS LEU GLN LEU SEQRES 1 D 196 GLY THR ILE PRO LYS PRO THR LEU TRP ALA GLU PRO ASP SEQRES 2 D 196 SER VAL ILE THR GLN GLY SER PRO VAL THR LEU SER CYS SEQRES 3 D 196 GLN GLY SER LEU GLU ALA GLN GLU TYR ARG LEU TYR ARG SEQRES 4 D 196 GLU LYS LYS SER ALA SER TRP ILE THR ARG ILE ARG PRO SEQRES 5 D 196 GLU LEU VAL LYS ASN GLY GLN PHE ARG ILE PRO SER ILE SEQRES 6 D 196 THR TRP GLU HIS THR GLY ARG TYR GLY CYS GLN TYR TYR SEQRES 7 D 196 SER ARG ALA ARG TRP SER GLU LEU SER ASP PRO LEU VAL SEQRES 8 D 196 LEU VAL MET THR GLY ALA TYR PRO LYS PRO THR LEU SER SEQRES 9 D 196 ALA GLN PRO SER PRO VAL VAL THR SER GLY GLY ARG VAL SEQRES 10 D 196 THR LEU GLN CYS GLU SER GLN VAL ALA PHE GLY GLY PHE SEQRES 11 D 196 ILE LEU CYS LYS GLU GLY GLU ASP GLU HIS PRO GLN CYS SEQRES 12 D 196 LEU ASN SER GLN PRO HIS ALA ARG GLY SER SER ARG ALA SEQRES 13 D 196 ILE PHE SER VAL GLY PRO VAL SER PRO ASN ARG ARG TRP SEQRES 14 D 196 SER HIS ARG CYS TYR GLY TYR ASP LEU ASN SER PRO TYR SEQRES 15 D 196 VAL TRP SER SER PRO SER ASP LEU LEU GLU LEU LEU VAL SEQRES 16 D 196 PRO FORMUL 5 HOH *86(H2 O) HELIX 1 1 ALA A 49 GLN A 54 1 6 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 VAL A 152 GLY A 162 1 11 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLU A 253 GLN A 255 5 3 HELIX 8 8 LEU D 54 ASN D 57 5 4 HELIX 9 9 THR D 66 THR D 70 5 5 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N GLY A 26 O PHE A 33 SHEET 4 A 8 SER A 4 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 A 8 THR A 94 LEU A 103 -1 O TRP A 97 N SER A 9 SHEET 6 A 8 LEU A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O LEU A 126 N GLU A 114 SHEET 8 A 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 B 4 LYS A 186 VAL A 194 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 B 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 VAL A 194 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 O TRP A 204 N HIS A 188 SHEET 3 C 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 3 ILE A 214 ARG A 219 0 SHEET 2 D 3 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 3 D 3 LEU A 270 LEU A 272 -1 O LEU A 272 N CYS A 259 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 E 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O TYR B 66 N CYS B 25 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 GLU B 44 ILE B 46 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LEU B 39 O ILE B 46 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 H 3 THR D 7 TRP D 9 0 SHEET 2 H 3 VAL D 22 GLN D 27 -1 O GLN D 27 N THR D 7 SHEET 3 H 3 GLN D 59 ILE D 62 -1 O ILE D 62 N VAL D 22 SHEET 1 I 4 VAL D 15 THR D 17 0 SHEET 2 I 4 LEU D 90 THR D 95 1 O VAL D 93 N ILE D 16 SHEET 3 I 4 GLY D 71 SER D 79 -1 N TYR D 73 O LEU D 90 SHEET 4 I 4 GLU D 34 ARG D 39 -1 N TYR D 38 O GLY D 74 SHEET 1 J 4 VAL D 15 THR D 17 0 SHEET 2 J 4 LEU D 90 THR D 95 1 O VAL D 93 N ILE D 16 SHEET 3 J 4 GLY D 71 SER D 79 -1 N TYR D 73 O LEU D 90 SHEET 4 J 4 ARG D 82 TRP D 83 -1 O ARG D 82 N SER D 79 SHEET 1 K 3 THR D 102 GLN D 106 0 SHEET 2 K 3 GLY D 115 GLU D 122 -1 O GLU D 122 N THR D 102 SHEET 3 K 3 ARG D 155 VAL D 163 -1 O PHE D 158 N LEU D 119 SHEET 1 L 4 GLN D 142 ASN D 145 0 SHEET 2 L 4 GLY D 129 GLU D 135 -1 N LEU D 132 O LEU D 144 SHEET 3 L 4 SER D 170 TYR D 176 -1 O ARG D 172 N CYS D 133 SHEET 4 L 4 LEU D 191 GLU D 192 -1 O LEU D 191 N HIS D 171 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS D 26 CYS D 75 1555 1555 2.05 SSBOND 5 CYS D 121 CYS D 173 1555 1555 2.04 SSBOND 6 CYS D 133 CYS D 143 1555 1555 2.04 CISPEP 1 TYR A 209 PRO A 210 0 0.20 CISPEP 2 HIS B 31 PRO B 32 0 0.45 CISPEP 3 GLU D 11 PRO D 12 0 -0.07 CISPEP 4 ARG D 51 PRO D 52 0 -1.18 CISPEP 5 GLN D 106 PRO D 107 0 0.03 CISPEP 6 GLY D 161 PRO D 162 0 0.00 CRYST1 81.400 81.400 186.733 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012285 0.007093 0.000000 0.00000 SCALE2 0.000000 0.014186 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005355 0.00000